Arvind A Chopra

age ~70

from Gaithersburg, MD

Get Report

Also known as:

Phone and address:: 123 Apple Blossom Way, Gaithersburg, MD 20878
3018696122

Connected to:

Arvind Chopra Phones & Addresses

a***[email protected]

Name / Title

Company / Classification

Phones & Addresses

Arvind Chopra
Director Of Quality Control

VIRxSYS Corporation
Pharmaceuticals · Noncommercial Research Organization

200 Perry Pkwy, Gaithersburg, MD 20877
3019870480

Keratinocyte Growth Factor-2 Formulations
view source
US Patent:

6653284, Nov 25, 2003
Filed:

May 14, 2001
Appl. No.:

09/853666
Inventors:

Reiner L. Gentz - Rockville MD
Arvind Chopra - Gaithersburg MD
Parveen Kaushal - Silver Springs MD
Thomas Spitznagel - Vienna VA
Edward Unsworth - Kensington MD
Fazal Khan - Gaithersburg MD
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

A61K 3818
US Classification:

514 12, 514 2, 424 851
Abstract:

The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.

Human B-Cell Translocation Genes-2 And 3 Antibodies
view source
US Patent:

6689360, Feb 10, 2004
Filed:

Apr 30, 2001
Appl. No.:

09/843846
Inventors:

Charles A. Kunsch - Gaithersburg MD
Arvind Chopra - Gaithersburg MD
Craig A. Rosen - Laytonsville MD
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

A61K 39395
US Classification:

4241331, 4241301, 4241351, 4241371, 4241381, 4241391, 4241411, 4241521, 4241721, 4241841, 5303871, 5303873, 5303877, 5303879, 5303881, 5303882, 5303891, 530350, 435 71, 435 702, 435 7021, 435 711
Abstract:

The present invention relates to antiproliferative genes. More specifically, isolated nucleic acid molecules are provided encoding the human B-cell translocation genes 2 and 3 (BTG-2 and BTG-3). BTG-2 and BTG-3 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to antibodies to BTG-2 and BGT-3.

Keratinocyte Growth Factor-2 Formulations
view source
US Patent:

6869927, Mar 22, 2005
Filed:

Jun 2, 2000
Appl. No.:

09/585541
Inventors:

Reiner L. Gentz - Rockville MD, US
Arvind Chopra - Gaithersburg MD, US
Parveen Kaushal - Silver Spring MD, US
Thomas Spitznagel - Vienna VA, US
Edward Unsworth - Kensington MD, US
Fazal Khan - Gaithersburg MD, US
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

A01N037/18
C12P021/06
A61K038/00
C12N015/00
C07H021/04
US Classification:

514 2, 514 12, 514925, 435 691, 435 694, 435243, 4353201, 435325, 530300, 530324, 530328, 530399, 530402, 536 2351
Abstract:

The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.

Diagnostic Methods Based On Human Btg-2 And Btg-3 Polypeptides
view source
US Patent:

7049081, May 23, 2006
Filed:

Dec 19, 2003
Appl. No.:

10/739043
Inventors:

Charles A. Kunsch - Norcross GA, US
Arvind Chopra - Gaithersburg MD, US
Craig A. Rosen - Laytonsville MD, US
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

G01N 33/53
C07K 14/00
A61K 38/17
US Classification:

435 71, 514 21, 530350, 436501
Abstract:

The present invention relates to novel antiproliferative genes. More specifically, isolated nucleic acid molecules are provided encoding the human B-cell translocation genes 2 and 3 (BTG-2 and BTG-3). BTG-2 and BTG-3 polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same.

Connective Tissue Growth Factor (Ctgf-3)
view source
US Patent:

7737257, Jun 15, 2010
Filed:

Dec 21, 2007
Appl. No.:

11/962282
Inventors:

Reinhard Ebner - Gaithersburg MD, US
Arvind Chopra - Gaithersburg MD, US
Steven M. Ruben - Brookeville MD, US
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

C07K 16/18
C07K 16/46
C07K 16/22
C07K 16/24
C07K 16/26
C12N 5/00
G01N 33/53
US Classification:

5303871, 5303873, 5303881, 5303891, 5303892, 5303913, 530866, 435 71, 435326
Abstract:

The present invention relates to a novel connective tissue growth factor-3 protein which is a member of the growth factor superfamily. In particular, isolated nucleic acid molecules are provided encoding the human connective tissue growth factor-3 protein. Connective tissue growth factor-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods for detecting and treating connective tissue related disorders.

Connective Tissue Growth Factor (Ctgf-3) Polypeptides
view source
US Patent:

7994284, Aug 9, 2011
Filed:

Apr 15, 2010
Appl. No.:

12/761083
Inventors:

Reinhard Ebner - Gaithersburg MD, US
Arvind Chopra - Gaithersburg MD, US
Steven M. Ruben - Brookeville MD, US
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

C07K 14/475
C07K 19/00
US Classification:

530350, 530324, 530395, 435 691
Abstract:

The present invention relates to a novel connective tissue growth factor-3 protein which is a member of the growth factor superfamily. In particular, isolated nucleic acid molecules are provided encoding the human connective tissue growth factor-3 protein. Connective tissue growth factor-3 polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods for detecting and treating connective tissue related disorders.

Myelin Oligodendrocyte Glycoprotein-Like Protein (Mogp)
view source
US Patent:

20030166898, Sep 4, 2003
Filed:

Jul 19, 2002
Appl. No.:

10/197844
Inventors:

Arvind Chopra - Gaithersburg MD, US
Henrik Olsen - Gaithersburg MD, US
Reiner Gentz - Rockville MD, US
Steven Ruben - Olney MD, US
Assignee:

Human Genome Sciences, Inc.
International Classification:

C07H021/02
C07H021/04
US Classification:

536/023100
Abstract:

The present invention relates to a novel MOGp protein which is a member of the Ig superfamily. In particular, isolated nucleic acid molecules are provided encoding the human MOGp protein. MOGp polypeptides are also provided as are vectors, host cells and recombinant methods for producing the same. Also provided are diagnostic and therapeutic methods for detecting and treating cancer, inflammation, and multiple sclerosis (MS).

Keratinocyte Growth Factor-2 Formulations
view source
US Patent:

20040063639, Apr 1, 2004
Filed:

Oct 30, 2003
Appl. No.:

10/695957
Inventors:

Reiner Gentz - Belo Horizonte-Mg, BR
Arvind Chopra - Gaithersburg MD, US
Parveen Kaushal - Silver Spring MD, US
Thomas Spitznagel - Vienna VA, US
Edward Unsworth - Kensington MD, US
Fazal Khan - Gaithersberg MD, US
Assignee:

Human Genome Sciences, Inc. - Rockville MD
International Classification:

A61K038/18
US Classification:

514/012000
Abstract:

The invention is directed to liquid and lyophilized forms of Keratinocyte Growth Factor-2 (KGF-2) and derivatives thereof. This invention further relates to the formulation of KGF-2 for therapeutic use, for example, to promote or accelerate wound healing.